« Back

MS Treatment 'Gilenya'

Tuesday March 20 2012 03:16 PM

UK Recommends MS Treatment Gilenya, Medicine Remains Currently Unavailable To Patients in Ireland

 • NICE – National Institute of Clinical Excellence (UK) recommends that Gilenya is made available to patients in England and Wales

• The once a day oral therapy is twice as effective as current conventional treatment1

• Gilenya – already available in the majority of EU countries – is still not reimbursed in Republic of Ireland despite being considered cost effective in September 2011.

• MS patient group calls for immediate access to the new treatment

The Department of Health’s delay in making Gilenya available to Irish MS patients was thrown into sharp focus following a decision by the National Institute for Clinical Excellence (NICE) in the UK. This is despite calls for its immediate introduction from leading Irish medical experts and MS Ireland.

NICE recommends fingolimod for the treatment of highly active relapsing remitting multiple sclerosis confirming it as a valuable, innovative and cost-effective therapy. This endorsement means those with MS in England and Wales will now have access to this innovative first ever oral medication to prevent their disability from progressing.

Healthcare systems in the vast majority of EU countries have taken steps to make Gilenya available to their citizens including Germany, Denmark, Switzerland, Sweden, Austria, Greece, Spain, Norway, France, Belgium the Netherlands and Italy.

MS Ireland’s Chief Executive, Ava Battles, said: “MS Ireland believes that this disease modifying therapy would be an important addition to the choice of treatments available to people with MS. It is not acceptable that people with MS in Ireland have less choice of treatments that are capable of modifying the progress of their illness than counterparts in Britain and other EU countries.

”We have written to the Minister and the Department on this matter and anticipate it will be treated as a matter of urgency.”

Download full press release here.

Author: MS Ireland/Novartis

Tags: news, research, gilenya

Comments

Add a comment

Your email address will not be published and will only be used by MS Ireland to contact you should there be an issue with your comment.

Please read our policy on making comments. Basically, respect other people’s view, use appropriate language and be nice! Comments are published between 9am and 5pm, Monday to Friday.

We ask this question to ensure that you are a real person, and not a computer adding information automatically.

By commenting, you are adhering to our Terms of use / Privacy

Latest News

More news

What's hot

Small_camera-photographer-yellow-photography

Enter our 2020 Calendar Competition!

Calling all budding photographers! Enter our competition to see YOUR photo in our new calendar!

Find out more

Events Calendar

» Our next Event

26 June 2019: Physiotherapist led Exercise classes for people with MS, starts 9th January (ongoing)

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow